1. Bupropion improved symptoms in adults with attention deficit hyperactivity disorder.
- Author
-
Ferre JC and Nutt D
- Abstract
QUESTION: In adults with attention deficit hyperactivity disorder (ADHD), is bupropion more effective than placebo?Design6 week randomised (allocation concealed*), blinded {clinicians, patients, and outcome assessors}*, placebo controlled trial.SettingPsychopharmacology clinic of the Massachusetts General Hospital, Boston, Massachusetts, USA.Patients40 patients who were 20-59 years of age (mean age 38 y, 55% men) and had ADHD according to DSM-IV criteria. Exclusion criteria were clinically significant chronic medical conditions, history of cardiac arrhythmias or seizures, intellectual impairment (intelligence quotient < 75), organic brain disorders, clinically unstable psychiatric conditions, bipolar disorder, drug or alcohol abuse within the past 6 months, or current use of psychotropics. 38 patients (95%) completed the study.InterventionPatients were allocated to 200 mg/day of bupropion (n=21) or placebo (n=19). The dose was tirated up to 200 mg twice daily by week 4.Main outcome measuresADHD, depression, and anxiety symptoms were measured using the Clinical Global Impression (CGI) scale, the ADHD Rating Scale, the Hamilton Depression Rating Scale (HDRS), the Beck Depression Inventory (BDI), and the Hamilton Anxiety Rating Scale (HARS). Adverse events were also assessed.Main resultsMore patients who received bupropion showed improvement than those who received placebo (score of 1 or 2 [much or very much improved] on the CGI scale, p = 0.007; and 330% reduction in scores on the DSM-IV ADHD symptom checklist, p=0.02) (table). More ADHD symptoms improved in the bupropion group patients than in placebo group patients (100% a 44% of symptoms, p < 0.001). The groups did not differ for scores on the HDRS, the BDI, or the HARS. The groups did not differ for adverse events (table); no serious adverse drug events occurred.ConclusionIn adults with attention deficit hyperactivity disorder, bupropion was more effective than placebo in improving symptoms and did not produce severe adverse effects.*See glossary.** Information provided by author. [ABSTRACT FROM AUTHOR]
- Published
- 2001